NCT04922658 2024-07-31
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Unknown
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
The First Affiliated Hospital of Xiamen University
Gruppo Oncologico Italiano di Ricerca Clinica